Trial intelligence / Profile preview

Food effect on nilotinib pharmacokinetics with tailored dose reduction in chronic myeloid leukemia

NL-OMON23914Completed

Sponsor
Vrije University Medical Center
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Trial of nilotinib, sponsored by Vrije University Medical Center. Started Dec 2015; status: completed.

02

Drugs

nilotinib

Beyond the preview

Go deeper on NL-OMON23914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call